Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  HSP90 inhibitor PU-H71
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Hsp90 Inhibitor PU-H71 and Nab-Paclitaxel in Treating Patients with HER2 Negative Metastatic Breast Cancer
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 17-093, NCI-2017-01207, NCT03166085
Start Over